Production beat the top of guidance by 5%, full-year guide went up, and net income still dropped from $497M to $346M.
Thesis: Guyana is de-bottlenecking above nameplate in real time while unit costs fall, so volume growth outruns cost growth and cash flow compounds faster than revenue. The earnings decline is a sales-timing and price artifact (325,000 bbl underlift, lower realizations), not operational decay. The whole setup rests on one partner's project execution and a government approval calendar, which is the only real discount to apply.
Verdict: LONG — Conviction: MEDIUM
Catalyst: Payara FPSO first oil early Q4 2023 adding ~220,000 gross bopd, plus the Wauru approval management expected 'hopefully this week' and the Whiptail plan of development submission later this year.
Key Risk: Brent materially below $70 with only 130,000 bopd hedged (roughly a third of production), while ExxonMobil or Guyana approvals slip and compress the 25% cash flow growth story at once.
The Tell: Greg Hill volunteered, unprompted, that Liza Phase 2 'has a nameplate of 220... it's been operating kind of 230 or so on a regular basis, but we'll pick that up towards 250 by the end of the year.' Management gave away upside capacity detail no analyst asked for. Confidence in the de-bottleneck is real, not guided.
Friction Level: MODERATE_FRICTION — Both sides accept the production beat and clean balance sheet. The dispute is whether ExxonMobil's execution and Guyana approval timing are dependable enough to underwrite 25% annual cash flow growth through 2027, or whether that is cancellable schedule.
Report not found
The report data is no longer available. Please return to the archive.